Norway· NO-ID_D83B0898-8B9C-483D-A064-91220A0DE145
Aldara
A imiquimod product containing imiquimod, registered in Norway by Viatris Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Imiquimod is registered in 16 of 19 countries.
Countries holding a registration under ATC D06BB10 (imiquimod), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Imiquimod · ATC D06BB10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Imiquimod
- Manufacturer
- Viatris Healthcare Limited
- Country
- Norway (NO)
- ATC code
- D06BB10
- ATC class
- Imiquimod
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_D83B0898-8B9C-483D-A064-91220A0DE145
- no_varenummer45286212 x 1NOK 701
- gtin7046264528624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
74 interactions on record for imiquimod.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imiquimod · interactions on record
74 records
- 1 severe
- 3 moderate
- 70 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- VerteporfinS01LA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Imiquimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesImiquimodPadagis Israel Pharmaceuticals Ltd
- United KingdomAldara 5% cream 250mg sachetsSigma Pharmaceuticals Plc
- FinlandAldaraViatris Healthcare Limited
- SpainALDARA 5% CREMAViatris Healthcare Limited
- CzechiaALDARAVIATRIS HEALTHCARE LIMITED, Dublin
- SwitzerlandAldara
- CanadaALDARA PBAUSCH HEALTH, CANADA INC.
- FranceALDARA 5 %, crèmeVIATRIS HEALTHCARE (IRLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Imikeraderm
- Cyprus · Modiwart
- Germany · Aksunim, Imikeraderm
- Spain · Imikeraderm, Imunocare
- United Kingdom (Northern Ireland) · Bascellex
- Greece · Modiwart, Quimodia
- Iceland · Aldara, Zyclara
- Italy · Imunocare
- Liechtenstein · Aldara, Zyclara
- Netherlands · Bascellex
- Poland · Imikeraderm
- Portugal · Imicare
- Sweden · Bascellex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4e74de8-ee09-4938-b5ac-090d797b6331 GET /v1/drugs/b4e74de8-ee09-4938-b5ac-090d797b6331?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "fest",
"status": "A",
"atc_name": "Imiquimod",
"merkevare_id": "ID_D83B0898-8B9C-483D-A064-91220A0DE145",
"name_form_strength": "Aldara krem 5 %",
"prescription_group": "C"
}See everything about imiquimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.